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Objectives:Cumulative radiation dose, cost, and increased demand for computed tomography aortography (CTA) suggest
that duplex ultrasonography (DU) may be an alternative to CTA-based surveillance. We compared CTA with DU during
endovascular aneurysm repair (EVAR) follow-up.
Methods: Patients undergoing EVAR had clinical and radiological follow-up data entered in a prospectively maintained
database. For the purpose of this study, the gold standard test for endoleak detection was CTA, and an endoleak detected
on DU alone was assumed to be a false positive result. DU interpretation was performed independently of CTA and vice
versa.
Results: One hundred thirty-two patients underwent EVAR, of whom 117 attended for follow-up ranging from six
months to nine years (mean, 32 months). Adequate aneurysm sac visualisation on DU was not possible in 1.7% of
patients, predominantly due to obesity. Twenty-eight endoleaks were detected in 28 patients during follow-up. Of these,
24 were initially identified on DU (four false negative DU examinations), and eight had at least one negative CTA with
a positive DU prior to diagnosis. Twenty-three endoleaks were type II in nature and three of these patients had increased
sac size. There was one type I and four type III endoleaks. Two of these (both type III) had an increased sac size. Of 12
patients with increased aneurysm size of 5 mm or more at follow-up, five had an endoleak visible on DU, yet negative CTA
and a further five had endoleak visualisation on both DU and CTA. Of six endoleaks which underwent re-intervention,
all were initially picked up on DU. One of these endoleaks was never demonstrated on CTA and a further two had at least
one negative CTA prior to endoleak confirmation. Positive predictive value for DU was 45% and negative predictive value
94%. Specificity of DU for endoleak detection was 67% when compared with CTA, because of the large number of false
positive DU results. Sensitivity for DU was 86%, with all clinically significant endoleaks demonstrated on CTA also
detected on DU.
Conclusion: Despite its low positive predictive value, we found DU to be a sensitive test for the detection of clinically
significant endoleaks. Given concerns about cumulative radiation exposure and cost, and the surprisingly low sensitivity
of CTA for endoleak detection in this series, selective CTA based on DU surveillance may be a more appropriate long-term
strategy. (J Vasc Surg 2009;49:60-5.)Endovascular aneurysm repair (EVAR) has been widely
adopted as a first line approach for the treatment of aortic
aneurysmal disease, particularly of the infrarenal aorta. Un-
certainty about the long term durability of endovascular
grafts as well as the known association between persistent
pressurisation of the aneurysm sac and aneurysm enlarge-
ment and subsequent rupture has made long term surveil-
lance of the aneurysm sac and the aortic stent a requirement
for all patients following EVAR.1 There has been much
debate about the ideal surveillance program, the frequency
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60of imaging required, and the optimal imaging strategy.
Most centres use a combination of computed tomography
aortography (CTA), duplex ultrasound (DU) scanning,
and plain abdominal radiography at six-month or yearly
intervals. However, concerns about the cumulative effects
of radiation from repeat CTA, and the resources involved
have led some to question whether duplex ultrasound
could replace CTA scanning.2,3 In the current study, we
aimed to compare the results of DU surveillance of endo-
vascular grafts with those of CTA surveillance of the same
patients, in order to determine whether patient follow-up
could be safely based on DU surveillance alone, with CTA
reserved only for those patients with positive, equivocal, or
inconclusive DU.
METHODS
All patients undergoing endovascular aneurysm repair
between 1996 and 2007 were entered into our surveillance
program and all clinical and radiological follow-up data as
well as treatment details were entered in our prospectively
maintained vascular database. Our surveillance program
JOURNAL OF VASCULAR SURGERY
Volume 49, Number 1 Manning et al 61consists ofCTAperformed six to eightweeks post-operatively,
at one year, and yearly thereafter, along with a plain abdom-
inal radiography, anteroposterior (AP), and lateral views.
Surveillance CT scans were biphasic, with initial non-contrast,
followed by arterial phase scans. As follow up progressed in
the absence of endoleak or increase in sac size, the initial
non-contrast component was omitted and arterial phase
only performed, using the previous non-contrast scan as a
reference. Where endoleak was suspected but not con-
firmed, or an increase in sac size noted, the patient was
recalled for a triphasic CTA using non-contrast, arterial
phase, and delayed phase CTA. Digital subtraction aortog-
raphy was performed selectively in patients with endoleak
or increase in sac size demonstrated on DU, CTA, or both.
DU was performed post-operatively and at six-month in-
tervals for the duration of follow-up, along with physical
examination. DU was performed by one of three experi-
enced vascular technicians using an ATL HDI 5000 or
IU22 ultrasound systems (Philips Medical Systems, Bothell,
Wash) with a 3.5 MHz transducer probe. Briefly, patients
were examined in the supine position with the head slightly
elevated at 10°. B-mode imaging was initially used to
identify the aorta, and maximum diameter of the aneurysm
sac was measured in the transverse plane. Patency of the renal
arteries was confirmed using spectral Doppler. The aorta
was scanned from the superior attachment of the endograft
to the inferior point in both transverse and saggital planes in
B mode. Using color and spectral Doppler, the stent was
assessed for perigraft flow, graft stenosis, thrombosis, or
kinking. We do not use intravenous contrast material dur-
ing DU, nor do we request that our patients fast overnight.
For the purpose of comparison for this study, CTA was
used as the gold standard test with which DU was com-
pared. The principal end point taken in this study was
detection of endoleak. If a patient had endoleak detected
on CTA, which was also demonstrated on DU, this was
regarded as a true positive result. An endoleak on DU not
found on CTA was a false positive, and an endoleak found
on CTA but not picked up on DU was a false negative. We
defined reintervention in this study as any planned thera-
peutic intervention which occurred during the course of
follow-up (ie, during the surveillance period, and not in the
immediate post-operative period). We have excluded diag-
nostic aortograms performed without intention to treat.
Data regarding aneurysm sac size on CTA and on DU was
also recorded and change in sac size of 5 mm or more in the
course of follow-up was reported as a significant increase or
decrease for the purposes of this comparison. In all cases,
the ultrasonographer was blind to the result of the CTA and
vice versa, with both CTA and the corresponding DU
performed on the same day in nearly all cases. After the
initial six-month period, twice as many DU examinations as
CT examinations were performed as per our protocol.
However, if DU was positive for the presence of endoleak
within six months of a previously negative CTA, a further
CTA was also performed at that time and the results com-
pared.RESULTS
Of 132 patients who underwent EVAR between April
1996 and May 2007, 117 had at least six months of
recorded follow-up based on a protocol including CTA,
DU, and plain radiography. The mean age of these patients
was 74  8 years (mean  SD; range, 51 to 88 years) with
amale to female ratio of 5.2:1. Themean duration of follow
up was 32 24 months (range, 6 to 108 months). Overall
462 CTA scans were performed (406 predicted from pro-
tocol) and 809 DU scans (857 predicted). The additional
studies were usually performed if endoleak was suspected or
an initial scan was inconclusive. Four hundred and six
paired examinations were performed, with DU and CTA
performed on the same day in almost every case. Remaining
DU scans were either perioperative scans, or six-monthly
scans between the annual CT, so in almost all cases DUwas
done within six months of the CT scan, if not on the same
day as the scan. In 1.7 % of cases DUwas inconclusive, in all
cases due to obesity.
In all, endoleaks were detected in 28 patients during
the course of follow-up, one type I, 23 type II, and four
type III, (one of these being from late fabric porosity [Table
I]). In 24 of 117 cases, endoleak was detected on both DU
and CTA, regarded as true positives for DU. Of these 24
patients, eight patients had a least one normal CTA scan
following a positive DU before the endoleak was demon-
strable on CTA. In 54 of 117 patients both CTA and DU
reported no evidence of endoleak (true negatives). There
were 33 patients with false positive DU scans, endoleaks
reported that were not confirmed by CT. Of these false
positives, four were positive for endoleak at the time of the
perioperative DU only and so, with no CT comparison
immediately postoperatively, these were not included as
false positives in further analysis. Two more cases were
positive at the six week scan with negative CT and subse-
quent DU scans negative. In four cases called false posi-
tives, the positive DU was associated with an increase in
aneurysm sac size, despite a negative CT scan. In one of
these cases, a type III endoleak (due to increased fabric
porosity) was eventually diagnosed at aortography and
further intervention was undertaken.
Of the 28 endoleaks detected and confirmed, 23 of
these were type II, and 13 of these occurred and were
detected perioperatively, within six weeks of EVAR. A
further five were detected within the first year, with five
more being detected subsequent to this and the latest at 53
months post-EVAR. One Type I endoleak was detected on
the first post-operative DU, as was one type III, with the
remaining three type III endoleaks detected at 42, 44, and
78 months post-treatment. In all but two cases, where
endoleaks were detected on DU, endoleak was also re-
ported on a least one subsequent scan, and in the two cases
where the follow-up scan was negative, follow-up CT also
confirmed resolution of the endoleaks. Of 23 type II en-
doleaks detected, eight had resolved at the time of last
follow-up.
ident
.
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did. In all four cases, DU subsequently demonstrated the
endoleak, and in all cases the endoleak was type II (see Fig 1).
In only one case was there an association with increase in
aneurysm sac size, and this was noted on DU. None of
these patients have undergone further intervention to date.
There were eight cases in which CTA may potentially have
given falsely negative results. Five cases have shown increase
in aneurysm sac size during the course of the follow-up, and
DUhas been positive for demonstration of endoleak.How-
ever CTA (triphasic) has not demonstrated endoleak. In a
further three cases, CTA was reported as negative yet
aneurysm sac size had increased and endoleak was subse-
quently diagnosed in a follow-up CT in two cases and at
aortography in the third. Endotension in this study was
defined as the presence of aneurysm sac enlargement in the
absence of detectable endoleak, on triphasic CTA or DU,
and two patients were in this category, both of whom had
negative triphasic CTA as well as DU, and one of whom
also had digital subtraction angiography, which failed to
detect an endoleak.
Of those patients diagnosed with an endoleak, six have
undergone re-intervention. In all six cases, DU was first
positive for endoleak. In one case, endoleak was never
detected on CTA (a late type III endoleak due to increased
fabric porosity), and in two further cases, at least one
Table I. Endoleaks detected during follow-up
Patient Endoleak type Time from EVAR (months)
1 II 60
2 II 14
3 II 30
4 III 66
5 III 44
6 II 42
7 II 12
8 II 3
9 III 24
10 II 42
11 II 3
12 II 2
13 II 12
14 II 2
15 II 2
16 II 6
17 II 6
18 II 2
19 II 2
20 I 2
21 III 72
22 II 36
23 II 2
24 II 2
25 II 2
26 II 2
27 II 2
28 II 2
CTA, computed tomography aortography; DU, duplex ultrasonography; E
*Endoleak initially negative on CTA, but positive on DU was subsequently
†An intervention where digital subtraction angiography only was performednegative CTAwas performed following a positive DU priorto confirmation of the endoleak. Six endoleaks were asso-
ciated with an increase in aneurysm sac size, three type III,
and three type II.
The positive-predictive value for DU when compared
with CTA (excluding DU results positive for early endoleak
only) was 45%, with a negative predictive value of 94%.
Sensitivity was calculated as 86% and specificity as 67%.
During the follow-up period, 32 patients were either
lost to follow-up or died. There were no conversions to
open repair in this series. There were two case of rupture.
The first was a patient in whom aneurysm sac size gradually
increased during the course of follow-up. DU always re-
ported the presence of an endoleak, which was not identi-
fied by triphasic CT or by aortography. The patient died 39
months post-operatively, at which time a decision had
already been taken that he was not fit for any further
intervention due to end stage respiratory disease. Rupture
was confirmed on CTA prior to the patient’s demise. The
second rupture occurred in a patient who presented acutely
to another institution and underwent open repair. Prior to
this, at his last follow-up 36 months postoperatively, aneu-
rysm size had been unchanged since surgery and no en-
doleak was noted on CTA or on DU.
Overall, in terms of sac size, 38% of aneurysms remained
unchanged (sac size within 5 mm of the pre-treatment
value), 52% had decreased in size, and 10% showed an
lex positive CTA positive Sac size Re-intervention
Yes Yes 2 No
Yes No* 2 No
Yes No* 2 No
Yes No* 1 Yes
Yes No* 1 Yes
Yes Yes 2 No
Yes Yes 2 No
Yes No* 1 Yes
†
Yes Yes 2 Yes
Yes Yes 2 No
No* Yes 2 No
Yes Yes 2 No
Yes Yes ↔ No
Yes No* ↔ No
No* Yes 1 No
No* Yes 2 No
Yes Yes ↔ No
Yes Yes 2 No
Yes Yes 2 No
Yes Yes 2 Yes
Yes No 1 Yes
Yes No* 1 No
Yes Yes ↔ No
Yes Yes ↔ No
Yes Yes 2 No
Yes Yes ↔ No
Yes Yes ↔ No
No* Yes ↔ No
endovascular aneurysm repair.
ified on CTA also or vice versa.Dup
VAR,increase in size during the course of follow-up, confirmed
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confirmed were significantly more likely to have an increase
in sac size during the course of follow-up (P  .01, Chi
squared test). There were three cases of graft migration,
detected on both CTA and plain radiographs, and all
associated with the development of endoleaks (two type III
and one type II), which required re-intervention. In all
cases, endoleak was detected on DU.
DISCUSSION
When DU is compared with CTA as the gold standard,
reported sensitivities have varied considerably, from 12 to
100%, with specificity ranging from 74-99% (see Table
Fig 1. (A) An example of a type II endoleak as demonstrated on
CTA. This was shown to originate from the inferior mesenteric
artery, and was not associated with an increase in aneurysm sac size,
and so was managed conservatively. (B) The same endoleak dem-
onstrated on duplex ultrasonography. The iliac limbs of the bifur-
cated endovascular device are shown, with abnormal color flow
visible in the aneurysm sac.II).4-9 In the present study, we report sensitivity of 86% anda negative predictive value of 94% for DU. Ramon et al
reported their experience in the only other larger series with
an equivalent follow-up time. Sensitivity for DU in this
report was only 42.9%, and the authors concluded that DU
could not replace CT scan in surveillance post EVAR. In
that series, of 35 cases of endoleak detected on CTA, 28 of
these were not picked up on DU.9 This contrasts with our
experience of 28 endoleaks, of which only four were not
initially detected on DU. Such differences highlight the
operator-dependent nature of ultrasound-based investiga-
tions and the need for individual institutions to validate
their own results rather than quoting the experience of
others. For such reasons, a comparison of DU with CTA in
endoleak detection may not lend itself well to meta-analysis
where pooled sensitivities are calculated. A recent such
study included authors who report 25% sensitivity8 with
those who report 97% for the same test,4 and excluded
larger series,7 not surprisingly concluding that DU should
not displace CT for aortic endograft surveillance.10
We have used biphasic CT scanning with non-contrast
and arterial phase contrast scans as our standard protocol,
reserving triphasic scan for cases where endoleak is sus-
pected but not confirmed or cases of sac enlargement in the
absence of endoleaks on a biphasic scan. Although non-
contrast scans are employed in all patients in the initial
follow-up (at six weeks), subsequently these scans are used
for reference in order to differentiate contrast from calcifi-
cation within the aneurysm sac. This has meant that arterial
phase only studies are performed after the first year of
follow-up, in order to reduce radiation dose. Plain abdom-
inal radiography remains an essential part of our surveil-
lance protocol, and has been previously reported as com-
parable to non-contrast CT for the detection of graft
migration and structural failure.11,12
The safety of routine triphasic CT scanning for all
patients undergoing follow-up post EVAR must be ques-
tioned. Although we accept that late type II endoleaks are
more likely to be picked up in the delayed post-contrast
phase, there is little evidence to suggest that this translates
to a clinically significant advantage, in a group of patients in
whom most aneurysms remain stable or shrink following
treatment. In fact, Iezzi et al, in the only prospective study
to address this issue, reported no significant difference in
sensitivity for endoleak detection between analysis of arte-
rial phase images alone, unenhanced and arterial phase
images, and arterial and delayed phase images, after the
initial follow-up at 1 month.13 In the current series as in
other similar studies,4,9,14 we did not routinely use triphasic
CT scans in the absence of aneurysm sac growth or positive
duplex findings. This may partly account for the apparently
superior sensitivity of DU scans over CTA. However, in the
eight patients in whom an increase sac size was noted,
without demonstrable endoleak on biphasic CT, in only
one case was an endoleak (type II) diagnosed when the
patients were recalled for triphasic scans.
Can our results justify modification of our surveillance
program to rely primarily on DU (in addition to plain film
radiography and clinical assessment) for surveillance, re-
using
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endoleak, or who have an increase in aneurysm sac size? The
present series has led to a significant change in our follow-up
algorithm (Fig 2). The safety of such an approach can be
estimated from examining those patients in whom DU
failed to detect an endoleak, which was picked up on CTA.
In each of the four cases, endoleak was classified as type II,
and although initially missed, all were noted on the subse-
quentDU. In only one case was there an increase in sac size,
but this was noted on the DU, alerting us to the need
for further evaluation. None of these patients required
Table II. Comparison of selected larger series comparing
angiograpy in post-endovascular aneurysm repair surveillan
Author Year n Follow-up (months)
Sato6 1998 79 n/a
Zannetti4 2000 103 8
Wolf5 2000 100 9
D’Audiffret9 2001 89 18
McWilliams8 2002 53 11
Raman7 2003 281 34.6
NPV, negative predictive value; PPV, positive predictive value.
Follow-up was mean number of months.
n/a, data not available.
*12% was for non-contrast enhanced DU, in this series, sensitivity was 50%
Fig 2. Our current algorithm for post-endovascular aneurysm
repair (EVAR) surveillance. Annual computed tomography an-
giography (CTA) has been omitted and CTA is now performed
only in the presence of a positive or inconclusive duplex ultra-
sonography (DU), or an increase in aneurysm sac size. *Clinical
assessment is carried out on each visit and our protocol also
includes yearly plain abdominal radiographs.re-intervention.Of the six patients in this series who required re-
intervention, three of these had initially normal CTA scans,
despite DU scans that reported the presence of an en-
doleak. Furthermore, in eight other cases, CTA may have
given falsely negative results as reported above. This in-
cludes five cases where there was an increase in sac size.
Perhaps the most striking evidence that the gold standard
CTA is less than the ideal tool for endoleak detection comes
from recent studies comparing it with magnetic resonance
angiography (MRA) in post-EVAR surveillance. Pitton et
al report sensitivity for endoleak detection of 92.9% for
magnetic resonance imaging (MRI) versus 44% for biphasic
CT in their follow-up study of 52 patients.15 Van der Lean
et al found that MRI detected endoleaks in 23 of 35 of the
patients who they studied, compared with only 11 of the
same group in whom endoleaks were detected by CTA.16
Both authors conclude that MRI is significantly more sen-
sitive than CTA for the detection of endoleaks. In light of
such reports, it is likely that the specificity and positive
predictive value of DU reported in this and previous stud-
ies, which have relied upon CTA as the gold standard, are
significantly underestimated, and false positive DU scans
may in fact be falsely negative CTA scans. We might con-
servatively estimate the specificity of DU in the present
series as 76% rather than 67% reported above.
In conclusion, we have shown DU to be a safe and
effective tool in post-EVAR surveillance. Varying reports in
the literature demonstrate the need for careful audit of DU
in individual units, by comparison with CTA or perhaps
ideally MRI. Where DU is validated as sensitive and with
high negative predictive value, it may safely replace CTA for
post-EVAR surveillance, with CTA being reserved for cases
of positive or inconclusive DU.
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